These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24300522)

  • 21. Simulating recurrent event data with hazard functions defined on a total time scale.
    Jahn-Eimermacher A; Ingel K; Ozga AK; Preussler S; Binder H
    BMC Med Res Methodol; 2015 Mar; 15():16. PubMed ID: 25886022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive trial design: a general methodology for censored time to event data.
    Jahn-Eimermacher A; Ingel K
    Contemp Clin Trials; 2009 Mar; 30(2):171-7. PubMed ID: 19130902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency of balanced treatment allocation for survival analysis.
    Kalish LA; Harrington DP
    Biometrics; 1988 Sep; 44(3):815-21. PubMed ID: 3203130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-stage design of clinical trials involving recurrent events.
    Cook RJ; Bergeron PJ; Boher JM; Liu Y
    Stat Med; 2009 Sep; 28(21):2617-38. PubMed ID: 19579215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesia and anesthesia for neonates: study design and ethical issues.
    Anand KJ; Aranda JV; Berde CB; Buckman S; Capparelli EV; Carlo WA; Hummel P; Lantos J; Johnston CC; Lehr VT; Lynn AM; Maxwell LG; Oberlander TF; Raju TN; Soriano SG; Taddio A; Walco GA
    Clin Ther; 2005 Jun; 27(6):814-43. PubMed ID: 16117988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size calculation for recurrent events data in one-arm studies.
    Rebora P; Galimberti S
    Pharm Stat; 2012; 11(6):494-502. PubMed ID: 23024035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 3: Design considerations.
    Ball G; Silverman MH
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S8-10. PubMed ID: 21664988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation in flexible two stage designs.
    Brannath W; König F; Bauer P
    Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical methods for the analysis of relapse data in MS clinical trials.
    Wang YC; Meyerson L; Tang YQ; Qian N
    J Neurol Sci; 2009 Oct; 285(1-2):206-11. PubMed ID: 19709676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
    Liu GF; Zhu GR; Cui L
    Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression analysis of panel count data with dependent observation times.
    Sun J; Tong X; He X
    Biometrics; 2007 Dec; 63(4):1053-9. PubMed ID: 18078478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A generalized estimating equation approach for modeling random length binary vector data.
    Albert PS; Follmann DA; Barnhart HX
    Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonparametric comparison for panel count data with unequal observation processes.
    Zhao X; Sun J
    Biometrics; 2011 Sep; 67(3):770-9. PubMed ID: 21114659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint.
    Xie T; Waksman J
    Stat Med; 2003 Sep; 22(18):2835-46. PubMed ID: 12953283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
    Schäfer H; Müller HH
    Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.